Aripiprazole
Aripiprazole is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Aripiprazole; Generic name: ARIPIPRAZOLE; Drug class: Atypical Antipsychotic [EPC].
| Brand name | Aripiprazole |
|---|---|
| Generic name | ARIPIPRAZOLE |
| Drug class | Atypical Antipsychotic [EPC] |
| Manufacturer | Amneal Pharmaceuticals LLC |
| Used for | 1 INDICATIONS AND USAGE Aripiprazole Tablets are indicated for the treatment of: Schizophrenia Irritability Associated with Autistic Disorder Treatment of Tourette’s Disorder Aripiprazole tablets are an atypical antipsychotic. Aripiprazole tablets are indicated for: Schizophrenia. ( 14.1 ) Irritability Associated with Autistic Disorder. ( 14.4 ) Treatment of Tourette’s Disorder. ( 14.5 ) |
| Dosage | 2 DOSAGE AND ADMINISTRATION Administer once daily without regard to meals ( 2 ) Initial Dose Recommended Dose Maximum Dose Schizophrenia – adults (2.1) 10 to 15 mg/day 10 to 15 mg/day 30 mg/day Schizophrenia – adolescents (2.1) 2 mg/day 10 mg/day 30 mg/day Irritability associated with autistic disorder – pediatric patients (2.4) 2 mg/day 5 to 10 mg/day 15 mg/day Tourette’s Disorder – (2.5) Patients <50 kg 2 mg/day 5 mg/day 10 mg/day Patients ≥50 kg 2 mg/day 10 mg/day 20 mg/day Known CYP2D6 poor |
| Warnings | WARNING: INCREASED MORTALITY IN ELDERLY PATIENTS WITH DEMENTIA-RELATED PSYCHOSIS and SUICIDAL THOUGHTS AND BEHAVIORS WITH ANTIDEPRESSANT DRUGS Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death. Aripiprazole is not approved for the treatment of patients with dementia-related psychosis [see Warnings and Precautions (5.1) ] . Antidepressants increased the risk of suicidal thoughts and behavior in children, adolescents, and young adul |
| Active ingredient(s) | ARIPIPRAZOLE |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=06dda03f-8481-46d6-af02-4f51e1a3a065 |